IDRA Financial Facts

Net loss: 20.47M
See Full Income Statement

Total liabilities and stockholders' equity: 960.53M
Property and equipment, net: 152.26M
See Full Balance Sheet

Idera Pharmaceuticals, Inc. (IDRA) Earnings

  |   Expand Research on IDRA
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +6.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/16/23 Q422 N/A-$0.12 N/A N/AN/A N/A N/A N/A
11/14/22 Q322 N/A-$0.11 N/A N/AN/A N/A N/A N/A
11/7/22 Q322 N/A-$0.11 N/A N/AN/A N/A N/A N/A
8/8/22 Q222 N/A-$0.11 N/A N/AN/A N/A N/A N/A
10/28/16 Q316 -$0.10-$0.12 +$0.02$323K$122K N/A Details
8/2/16 Q216 -$0.11-$0.11 $0.00$301K$143K N/A Details
5/9/16 Q116 -$0.11-$0.11 $0.00N/AN/A N/A Details
3/10/16 Q415 -$0.10-$0.11 +$0.01N/A$20M N/A Details